Works by Klippel, Zandra

Results: 18

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.

Published in:

2018

By:

Dale, David C.;
Crawford, Jeffrey;
Klippel, Zandra;
Reiner, Maureen;
Osslund, Timothy;
Fan, Ellen;
Morrow, Phuong Khanh;
Allcott, Kim;
Lyman, Gary H.

Publication type:

journal article

Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.

Published in:

2016

By:

Li, Yanli;
Klippel, Zandra;
Shih, Xiaolong;
Reiner, Maureen;
Wang, Hong;
Page, John;
Page, John H

Publication type:

journal article

Once‐weekly (70 mg/m<sup>2</sup>) vs twice‐weekly (56 mg/m<sup>2</sup>) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION‐1 trials.

Published in:

Cancer Medicine, 2020, v. 9, n. 9, p. 2989, doi. 10.1002/cam4.2945

By:

Moreau, Philippe;
Stewart, Keith A.;
Dimopoulos, Meletios;
Siegel, David;
Facon, Thierry;
Berenson, James;
Raje, Noopur;
Berdeja, Jesus G.;
Orlowski, Robert Z.;
Yang, Hui;
Ma, Haijun;
Klippel, Zandra;
Zahlten‐Kumeli, Anita;
Mezzi, Khalid;
Iskander, Karim;
Mateos, Maria‐Victoria

Publication type:

Article

Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia.

Published in:

Cancer Medicine, 2018, v. 7, n. 8, p. 4121, doi. 10.1002/cam4.1580

By:

Li, Yanli;
Chen, Lie H.;
Chao, Chun R.;
Family, Leila;
Page, John H.;
Klippel, Zandra;
Xu, Lanfang

Publication type:

Article

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01149-w

By:

Richardson, Paul G.;
Perrot, Aurore;
Mikhael, Joseph;
Martin, Thomas;
Beksac, Meral;
Spicka, Ivan;
Capra, Marcelo;
D'Agostino, Mattia;
Sonneveld, Pieter;
Bisht, Kamlesh;
Fukao, Taro;
Zhang, Rick;
Tada, Keisuke;
Tekle, Christina;
Macé, Sandrine;
Klippel, Zandra;
van de Velde, Helgi;
Moreau, Philippe

Publication type:

Article

In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019.

Published in:

2019

By:

Klippel, Zandra;
Kimball, Amy;
Tekle, Christina

Publication type:

Letter to the Editor

Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy.

Published in:

2016

By:

Li, Yanli;
Klippel, Zandra;
Shih, Xiaolong;
Wang, Hong;
Reiner, Maureen;
Page, John;
Page, John H

Publication type:

journal article

P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA‐HIGH‐RISK CYTOGENETICS: ICARIA‐MM AND IKEMA SUBGROUP ANALYSIS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970628.27700.c7

By:

Moreau, Philippe;
Perrot, Aurore;
Dimopoulos, Meletios A.;
Martin, Thomas;
Facon, Thierry;
Eduardo Capra, Marcelo;
Beksac, Meral;
Armstrong, Nicole;
Dubin, Franck;
Macé, Sandrine;
Risse, Marie‐Laure;
Tekle, Christina;
Klippel, Zandra;
Richardson, Paul

Publication type:

Article

P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM IN THE ICARIA-MM AND IKEMA STUDIES.

Published in:

2023

By:

Perrot, Aurore;
Richardson, Paul;
Mikhael, Joseph;
Martin, Thomas G.;
Beksac, Meral;
Spicka, Ivan;
Eduardo Capra, Marcelo;
D'agostino, Mattia;
Sonneveld, Pieter;
Bisht, Kamlesh;
Fukao, Taro;
Zhang, Rick;
Tada, Keisuke;
Tekle, Christina;
Macé, Sandrine;
Klippel, Zandra;
van de Velde, Helgi;
Moreau, Philippe

Publication type:

Abstract

Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series.

Published in:

2018

By:

Vesole, David H.;
Richter, Joshua;
Biran, Noa;
McBride, Laura;
Anand, Palka;
Huang, Mei;
Kumeli, Anita-Zahlten;
Klippel, Zandra;
Iskander, Karim;
Siegel, David S.

Publication type:

Case Study

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.

Published in:

Amyloid, 2016, v. 23, n. 4, p. 254, doi. 10.1080/13506129.2016.1258356

By:

Cowan, Andrew J.;
Klippel, Zandra K.;
Stevenson, Philip A.;
Hyun, Teresa S.;
Tuazon, Sherilyn;
Becker, Pamela S.;
Green, Damian J.;
Holmberg, Leona A.;
Coffey, David G.;
Gopal, Ajay K.;
Libby, Edward N.

Publication type:

Article

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).

Published in:

2017

By:

Pinter, Tamás;
Klippel, Zandra;
Cesas, Alvydas;
Croitoru, Adina;
Decaestecker, Jochen;
Gibbs, Peter;
Hotko, Yevhen;
Jassem, Jacek;
Kurteva, Galina;
Novotny, Jan;
O'Reilly, Seamus;
Salek, Tomas;
Reiner, Maureen;
Morrow, Phuong Khanh;
Mi Rim Choi;
Whittaker, Sadie;
Blanke, Charles;
Choi, Mi Rim

Publication type:

journal article

Validation of claims algorithms for Progression to Metastatic cancer in Patients with Breast, non-small cell lung, and colorectal cancer.

Published in:

Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00018

By:

Nordstrom, Beth L.;
Simeone, Jason C.;
Malley, Karen G.;
Fraeman, Kathy H.;
Klippel, Zandra;
Durst, Mark;
Page, John H.;
Hairong Xu;
Cuncong Zhong;
Siddique, Hifzur Rahman;
Jamal, Mohammad Sarwar

Publication type:

Article

Isatuximab–dexamethasone–pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 12, p. 2087, doi. 10.1002/psp4.13206

By:

Pitoy, Antoine;
Desmée, Solène;
Riglet, François;
Thai, Hoai‐Thu;
Klippel, Zandra;
Semiond, Dorothée;
Veyrat‐Follet, Christine;
Bertrand, Julie

Publication type:

Article

Carfilzomib (K) in relapsed and refractory multiple myeloma (RRMM): frailty subgroup analysis from phase 3 ASPIRE and ENDEAVOR.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e266, doi. 10.1016/j.clml.2019.07.299

By:

Facon, Thierry;
Niesvizky, Ruben;
Weisel, Katja;
Bringhen, Sara;
Ho, P. Joy;
Obreja, Mihaela;
Yang, Zhao;
Klippel, Zandra;
Blaedel, Julie;
Mezzi, Khalid;
Siegel, David S.

Publication type:

Article

Carfilzomib (K) in Relapsed and Refractory Multiple Myeloma (RRMM): Frailty Subgroup Analysis from Phase 3 ASPIRE and ENDEAVOR.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S320, doi. 10.1016/j.clml.2019.07.299

By:

Facon, Thierry;
Niesvizky, Ruben;
Weisel, Katja;
Bringhen, Sara;
Ho, P. Joy;
Obreja, Mihaela;
Yang, Zhao;
Klippel, Zandra;
Blaedel, Julie;
Mezzi, Khalid;
Siegel, David

Publication type:

Article

Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.

Published in:

2019

By:

Shah, Jatin;
Usmani, Saad;
Stadtmauer, Edward A.;
Rifkin, Robert M.;
Berenson, James R.;
Berdeja, Jesus G.;
Lyons, Roger M.;
Klippel, Zandra;
Chang, Yu-Lin;
Niesvizky, Ruben

Publication type:

journal article

Phase 3 Study (CLARION) of Carfilzomib, Melphalan, Prednisone (KMP) v Bortezomib, Melphalan, Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e26, doi. 10.1016/j.clml.2017.03.045

By:

Facon, Thierry;
Lee, Jae Hoon;
Moreau, Philippe;
Niesvizky, Ruben;
Dimopoulos, Meletios Athanasios;
Hajek, Roman;
Osman, Muhtarjan;
Aggarwal, Sanjay;
Klippel, Zandra;
San Miguel, Jesus

Publication type:

Article